Stock Track | Clover Health Plummets 5.35% Intraday on Mixed Earnings and 2026 Guidance Concerns

Stock Track
02/27

Clover Health Corp (CLOV) saw its stock price plummet by 5.35% during intraday trading on Friday.

The decline follows the company's release of mixed quarterly financial results and forward-looking guidance. Clover Health reported a quarterly adjusted loss of 10 cents per share for the period ended September 30, 2025, with revenue growing 47.4% year-over-year to $487.71 million. However, the company posted a substantial quarterly loss of $49.32 million, representing a deterioration from the same quarter last year.

Investors reacted negatively to the company's full-year 2026 revenue guidance of $2.81 billion to $2.92 billion, indicating concerns about continued losses despite revenue growth and uncertainty over the path to profitability.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10